Altha Clinical Research Clarksville, TN - 37043

Altha Clinical Research is categorized under Market Research and Analysis in Clarksville, TN .

Altha Clinical Research was established in 0, and today employs 1 to 4, earning Unknown per year. This is a Market Research and Analysis business, which does work in the B2B market, and is classified as a Market Research and Analysis, under code number 5419100 by the NAICS.

If you are seeking more information, feel free to contact Kathy Maddox, President at the company’s single location by writing to 279 Clear Sky Court # C, Clarksville, Tennessee TN 37043 or by phoning (931) 920-2525. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Altha Clinical Research
Contact Person: Kathy Maddox, President
Address: 279 Clear Sky Court # C, Clarksville, Tennessee 37043
Phone Number: (931) 920-2525
Website Address: alphaclinicalresearch.com
Annual Revenue (USD): Unknown
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Market Research and Analysis
SIC Code: 8732
NAICS Code: 5419100
Share This Business:

Altha Clinical Research was started in 0 to provide professional Market Research and Analysis under the SIC code 8732 and NAICS code 5419100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.

Feel free to contact Kathy Maddox, President for inquiries that concern Altha Clinical Research by calling the company number (931) 920-2525, as your correspondence is most welcome. Additionally, the physical location of the single location of Altha Clinical Research can be found at the coordinates 36.4964,-87.234 as well as the street address 279 Clear Sky Court # C in Clarksville, Tennessee 37043.

For its online presence, you may visit Altha Clinical Research’s website at alphaclinicalresearch.com and engage with its social media outlets through on Twitter and on Facebook.